The Motley Fool Highlights Top Pharmaceutical Stocks for 2026 Key Trends and Investment Considerations IRMD Q1 2026 Earnings EPS Beats Estimates Revenue Details Not Disclosed Mortgage Rates Ease Slightly but Remain Above 65 Threshold